Bellerophon Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Bellerophon Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2022.
  • Bellerophon Therapeutics, Inc. Operating Lease, Payments for the quarter ending June 30, 2023 was $8K, a 95.9% decline year-over-year.
  • Bellerophon Therapeutics, Inc. Operating Lease, Payments for the twelve months ending June 30, 2023 was $599K, a 22.8% decline year-over-year.
  • Bellerophon Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $783K, a 1.69% increase from 2021.
  • Bellerophon Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $770K, a 1.72% increase from 2020.
  • Bellerophon Therapeutics, Inc. annual Operating Lease, Payments for 2020 was $757K, a 10.8% increase from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $783K +$13K +1.69% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 $770K +$13K +1.72% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $757K +$74K +10.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $683K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.